UK guidelines include starting treatment with two nukes plus a third drug.
The 2012 draft recommendations are summarised below.
| Preferred | Alternative | |
| Two ‘nukes’ | tenofovir + FTC (Truvada) | abacavir + 3TC (Kivexa) |
| Plus a third drug | efavirenz (NNRTI) or
atazanavir/r (boosted PI) or darunavir/r (boosted PI) or raltegravir (integrase inhibitor) |
lopinavir/r (boosted PI) or
fosamprenavir/r (boosted PI) or nevirapine (NNRTI) or rilpivirine (NNRT |
April 2012
Decisions relating to your treatment should always be taken in consultation with your doctor. Information in this guide is intended to support those discussions.
Authors and references • Translations • About our guides • Guides index
This guide's available in UK clinics (can't find it?)
We comply with the HONcode standard for trustworthy health information: verify here
HIV i-Base
Treatment phoneline: 0808 800 6013 • Mon-Wed 12-4pm • Office: 020 7407 8488 • Email: admin@i-base.org.uk • Website: www.i-base.info